{"id":"938","presentation":"P-16.1.1 - Prospective Comparison of Sham vs. Placebo Injections: Data from a Trial of Lorecivivint, a Wnt Pathway Inhibitor for Knee Osteoarthritis","session":"0.0 - Poster Viewing \/ Coffee Break \/ Exhibition","filename":"Tambiah 16.1.1.pptx","speaker":"J. Tambiah<small> (San Diego, US)<\/small>","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/icrs2019\/persons\/photos\/622.jpg","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-presentations\/icrs2019\/938\/jpg\/tambiah16.1.1\/thumbnails\/0.png","html5":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-presentations\/icrs2019\/938\/html\/tambiah16.1.1\/data\/","what":"html5","code":"","priority":["html5","pdf","jpg","thumbnail"]}
[speaker]
[presentation]
[session]